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Abstract 
Background: Sialyl‑Lewis X/L‑selectin high affinity binding interactions between transmembrane O‑glycosylated 
mucins proteins and the embryo have been implicated in implantation processes within the human reproductive sys‑
tem. However, the adhesive properties of these mucins at the endometrial cell surface are difficult to resolve due to 
known discrepancies between in vivo models and the human reproductive system and a lack of sensitivity in current 
in vitro models. To overcome these limitations, an in vitro model of the human endometrial epithelial was interrogated 
with single molecule force spectroscopy (SMFS) to delineate the molecular configurations of mucin proteins that 
mediate the high affinity L‑selectin binding required for human embryo implantation.
Results: This study reveals that MUC1 contributes to both the intrinsic and extrinsic adhesive properties of the HEC‑1 
cellular surface. High expression of MUC1 on the cell surface led to a significantly increased intrinsic adhesion force 
(148 pN vs. 271 pN, p < 0.001), whereas this adhesion force was significantly reduced (271 pN vs. 118 pN, p < 0.001) 
following siRNA mediated MUC1 ablation. Whilst high expression of MUC1 displaying elevated glycosylation led to 
strong extrinsic (> 400 pN) L‑selectin binding at the cell surface, low expression of MUC1 with reduced glycosylation 
resulted in significantly less (≤200 pN) binding events.
Conclusions: An optimal level of MUC1 together with highly glycosylated decoration of the protein is critical for high 
affinity L‑selectin binding. This study demonstrates that MUC1 contributes to cellular adhesive properties which may 
function to facilitate trophoblast binding to the endometrial cell surface through the L‑selectin/sialyl‑Lewis x adhesion 
system subsequent to implantation.
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Background
Mucins are high molecular weight O- and N-glycosylated 
proteins present on the surface of human epithelial cells 
found in the reproductive, bladder, respiratory and diges-
tive tracts and can be secreted into the extracellular 
environment [1, 2]. Heavily glycosylated mucin structures 
act as barriers between the cell membrane and surround-
ing environment, shielding cells and tissues from toxins 
and proteolytic attack by bacteria and host proteases, 
and also function in cell adhesion, immune response and 
cell signalling [1–3]. Mucin protein glycosylation is ini-
tiated by glycotransferases, which catalyse the addition 
of N-acetylgalactosamine (GalNAc) through an O-gly-
cosidic linkage to hydroxyl groups present on serines or 
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theronines in the protein substrate [2]. The addition of 
GalNAc forms the foundation upon which highly ordered 
and complex oligosaccharide chains can be built through 
the addition of sugars including fucose, galactose, sialic 
acid and sialyl-Lewis X, leading to either linear or 
branched structures [2]. Sialyl-Lewis X is a mono-fuco-
sylated oligosaccharide which functions as a ligand to a 
family of adhesion molecules, the selectins (P-, L- and 
E- selectins) [4]. Selectins are type-1 transmembrane 
glycoproteins which display binding affinity to glycans 
containing α2,3-linked sialic acid and α1,3-linked fucose 
residues [5]. Whilst P- and E- selectins are involved in 
immune recognition of the embedded embryo in the 
endometrium and trophoblast migration within decidual 
spiral arterioles, L-selectin and its binding ligands have 
been shown to play a crucial role in mediating the adhe-
sion of the blastocyst to the endometrium [6].
The sialyl-Lewis X/L-selectin adhesion system has 
been implicated in many physiological processes, includ-
ing leukocyte infiltration (of vascular endothelial cell 
surfaces), lymphocyte homing, tumour metastasis, and 
therefore is an important glycan mechanism in cell-cell 
interactions [4, 7, 8]. Sialyl-Lewis X/L-selectin interac-
tions are required for successful implantation processes 
in the human reproductive system, mediating the adhe-
sion of the embryo to the uterine endometrial epithelium 
surface [4]. Glycosylation patterns on proteins present on 
the human endometrium cell surface, including sialyl-
Lewis X, are very dynamic, varying during embryogen-
esis, embryo implantation, invasion and placentation [4, 
9]. Sialyl-Lewis X epitope levels at the endometrial sur-
face peak during embryo implantation in healthy women 
[10], where blastocysts also demonstrate L-selectin 
expression [11, 12]. Also, in infertile women diagnosed 
with polycystic ovary syndrome (PCOS), endometrio-
sis or Unexplained Infertility (UIF) L-selectin levels are 
altered, suggesting correct glycosylation is critical in 
implantation [10].
Previous studies have shown that the transmembrane 
mucins MUC1 and MUC16 are the two major mucins 
present on the surface of endometrial epithelial cells, 
whereas MUC4 is virtually absent, however their func-
tion in the reproductive process is yet to be fully resolved 
[13, 14]. The ability of the embryo to undergo the pro-
cess of apposition at the endometrial surface appears to 
involve a delicate balance between adhesive and anti-
adhesive properties of the surface glycocalyx; a mucin 
protein rich endometrial surface layer which may act as 
a natural barrier to the embryo attachment, except at 
the site of apposition [15–17]. In vivo studies in a trans-
genic mouse model showed that the loss of MUC1 at 
sites of implantation correlated with embryo attach-
ment, however, in humans expression of MUC1 is high 
during peri-implantation indicating its  possible role in 
this process [17, 18]. MUC1 can be decorated with sia-
lyl-Lewis X in endometrial cells [4, 19] and expression 
of MUC1 in the infertile endometrium is significantly 
different than in fertile endometrium [20]. This suggests 
that MUC1 glycosylation in humans may promote ini-
tial recognition and adhesion events between MUC1 and 
the embryo, which could subsequently guide the embryo 
to the implantation site [20]. MUC16 also plays a role in 
modulating implantation, and loss of MUC16 has been 
shown to enhance trophoblast adherence in vitro [21]. 
Conversely, another study revealed an increase in endo-
metrial MUC16 transcript levels in the receptive phase of 
fertile women, and a decreased transcript level in women 
with IVF failure [22]. Because of the known discrepan-
cies between in vivo models and the human reproductive 
system and conflicting information within the literature, 
we developed an in vitro model to investigate the role of 
glycosylated MUC1 in L-selectin recognition in relation 
to the initial interaction of the blastocyst with the mucin 
layer extending far above the cell surface [13, 20].
In this study, we used single molecule force spectros-
copy (SMFS) to probe endometrial epithelial cells to 
describe the nanoscale binding events that occur between 
L-selectin and mucin proteins. Using this in vitro assay 
we have been able to elucidate the adhesive and anti-
adhesive roles of MUC1, and thus determine what 
appears to be an important role in the first critical stage 
in embryo recognition, crucial for human reproduction.
Results
Mucins facilitate intrinsic endometrial cell surface 
adhesion
Mucins are important components of the endometrial 
cell glycocalyx layer and possess long elongated and flex-
ible structures that extend well beyond the cell surface 
[23]. These mucins have a highly glycosylated central pro-
tein domain of tandemly repeating sequences, known as 
VNTRs (variable number tandem repeats), resembling 
an extended bottle brush like conformation (Fig.  1a). It 
is these highly glycosylated regions of the mucin strands 
which facilitate adhesive and anti-adhesive interactions 
on the cell surface [24]. However, the intrinsic and extrin-
sic adhesive role of MUC1 extending from the endome-
trial cell surface in successful implantation is currently 
disputed due to conflicting literature derived from in 
vitro and in vivo studies.
In this study, we performed AFM PFQNM mapping to 
quantify the intrinsic adhesive properties of HEC-1A and 
HEC-1B cell lines (Fig. 1b and c). The endometrial adeno-
carcinoma HEC-1 cell line was selected for this study 
as the cell line expresses MUC1 (HEC-1B is a substrain 
of HEC-1A) and has been widely used in implantation 
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research [25]. While no differences in cellular stiffness 
and deformation were identified between HEC-1A and 
HEC-1B cell lines, a significantly increased adhesion 
force was measured for HEC-1B cells (271pN) when com-
pared to HEC-1A cells (148pN, p < 0.001; Fig.  1b and c). 
Cell stiffness and deformation are mechanical properties 
linked to a cells sub-membranous cytoskeletal structure, 
while adhesion force is linked to the presence of mem-
brane proteins on the cell surface [26, 27]. In this study, 
forces derived from the retraction part of the force curve 
measurements was used to assess the adhesive proper-
ties of the mucin layer extending from the cell surface. 
This data demonstrates that HEC-1B cell surfaces have a 
greater intrinsic adherence compared to HEC-1A.
To determine if the intrinsic adhesion properties of 
HEC-1 cells was linked to mucin expression we estab-
lished a MUC1 specific siRNA knockdown model in 
HEC-1 cells. Protein expression analysis revealed that 
MUC1 protein expression was 3 times  greater in HEC-
1B cells (196 AU, Fig.  2a) compared to HEC-1A cells 
(46 AU). Also, MUC1 protein expression in HEC-1B 
and HEC-1A cells was significantly reduced by 53.9 % 
and 22.6 % respectively following MUC1 siRNA treat-
ment compared to scrambled siRNA (p ≤ 0.05; Fig.  2a). 
AFM PFQNM imaging of the HEC-1A and HEC-1B cells 
revealed no topographical differences (Fig. 2b and c) and 
no significant differences in cell deformation and stiffness 
(p > 0.05; Fig.  2d and e) after MUC1 siRNA treatment. 
However, for the MUC1 abundant HEC-1B cell line the 
adhesion force was significantly reduced from 271 ± 35 
pN to 118 ± 19 pN following siRNA mediated MUC1 
ablation (p < 0.001). The adhesion force for HEC-1A cells, 
expressing less MUC1, was also significantly reduced, but 
to a lesser extent, from 148 ± 19 pN to 117 ± 24 pN fol-
lowing siRNA treatment (Fig. 2d; p < 0.05).
To confirm that the reduction in adhesion force after 
MUC1 siRNA treatment was in fact due to MUC1 clear-
ance from the surface of HEC-1B and HEC-1A cells, we 
used an AFM probe functionalised with an antibody 
specific for the MUC1 extracellular VNTR domain 
region (Fig. 3). The magnitude of rupture forces achieved 
between the AFM probe and cell surface were lower for 
HEC-1A compared to HEC-1B cells (approximate peak 
values of 100 pN vs. 200 pN respectively) and were also 
reduced after siRNA treatment of HEC-1B cells (approxi-
mate peak values of 200 pN vs. 100 pN; Fig. 3). Non-spe-
cific anti-GAPDH antibody functionalised probes were 



















































Fig. 1 Endometrial epithelial cell mucins, mechanics and adhesion. a Schematic of transmembrane mucin MUC1 and Epidermal Growth Factor 
Receptor (EGFR) present on the endometrial cell surface, demonstrating MUC1 extension high above other surface receptor molecules. b AFM 
QNM surface adhesion images of HEC‑1A and HEC‑1B cell lines assessed with a non functionalized AFM probe. c Quantitative data of Cell Elasticity 
(kPa), Adhesion (pN) and Deformation (nm) from AFM QNM data from HEC‑1A and HEC‑1B cell lines with a non‑functionalized probe. Data shown 
is based on a minimum of three biological repeats, with three cellular areas per repeat (n = 9), analysed as parametric data using 2 tailed T test. 
Significance given as *** p < 0.001
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events were specific to MUC1 (Fig. 3b). Furthermore, the 
number of positive binding events measured in HEC-1B 
cells decreased after siRNA treatment. This study reveals 
that mucins, and specifically MUC1, contributes to the 
intrinsic adhesive properties on the surface of endome-
trial cells.
Development of an in vitro glycosylated MUC1 cell line 
model
A series of cytokine-manipulated (TNFα and IFNγ) 
HEC-1A and HEC-1B cell line models were developed 
to elucidate the specific role of glycosylated MUC1 in 
mediating L-selectin binding, which is thought to be cru-
cial in endometrial receptivity for the developing embryo 
(Fig.  4a and b). The highest MUC1 expression levels 
were again observed in HEC-1B cells (1.39 ± 0.15 to 
2.25 ± 0.51; Additional file 1: Table S1) and were lowest in 
HEC-1A cells (0.05 ± 0.01 to 0.20 ± 0.02; Additional file 1: 
Table  S1). The greatest increases in GlcNac expression 
occurred after treatment of the cell lines with IFNγ alone 
or in combination with TNFα (Model B-2–0.329 ± 0.030, 
Model A-2–0.240 ± 0.047; Additional file  1: Table  S1), 
while a reduction in GlcNac expression occurred after 
treatment of the cell lines with TNFα alone (Model 
B-3–0.028 ± 0.003, Model A-3–0.038 ± 0.019, Additional 
file 1: Table S1). Importantly, the cytokine treatments did 
not alter the viability of either the HEC-1A and HEC-1B 
cells, as determined by MTT assays (Additional file 1: Fig. 
S1).
Development of an in vitro L‑selectin SMFS model
To elucidate the extrinsic adhesive properties of MUC1 
in endometrial receptivity (Fig.  1a), we developed an in 
vitro SMFS assay by functionalising AFM probes with 
L-selectin. MUC1 has been implicated in fertility through 
the sialyl-Lewis X/L-selectin blastocyst adhesion system 
[4]. The functionalisation of AFM probes with L-selectin 
enabled the capacity for MUC1 to bind L-selectin to be 
characterised thereby providing mechanistic insights 
into blastocyst adherence at the endometrial surface. A 
flexible probe linker chemistry was used to ensure that 
L-selectin orientation was not limited, therefore maxim-
ising binding probability [28]. The presence of L-selectin 
on the AFM tip was inferred through comparing SMFS 
binding measurements on glass to those performed on 
HEC-1B and HEC-1A cell surfaces (Additional file 1: Fig. 
S2, Table S1). Non-specific anti-GAPDH antibody func-
tionalised probes, as a negative control, demonstrated 
only background adhesion on live cell surfaces below 
250  pN. Furthermore, L-selectin specific binding was 
validated through SMFS maps on HEC-1B and HEC-
1A cells treated with MUC1 siRNA, showing a loss of 
binding (See Additional file 1: Fig. S2). The SMFS meas-
urements made with the L-selectin functionalised probes 
revealed greater adhesion forces and adhesion energies 
for the MUC1-containing cell surfaces compared to the 
glass control (10.5 ± 0.9 vs. 325.9 ± 7 pN; 1.05 ± 0.27 vs. 
15.9 ± 0.4 aJ) and also with force measurements using 
non-functionalised probes (9.03 ± 0.47 vs. 325.9 ± 7 pN; 
0.59 ± 0.06 vs. 15.9 ± 0.4 aJ).
Increase in MUC1 and GlcNac expression correlates 
with enhanced L‑selectin binding
In order to examine the relative contribution of glyco-
sylated MUC1 in mediating L-selectin binding, HEC-1 
cells were interrogated with the L-selectin functional-
ised AFM probes. The MUC1 rich HEC-1B cells demon-
strated higher L-selectin mean binding values compared 
to the MUC1 poor HEC-1A cells for both adhesion 
force (0.466 ± 11 vs. 0.325 ± 7 nN) and binding distance 
(0.465 ± 4 vs. 0.343 ± 4 µm) (Fig.  5; Additional file  1: 
Table. S1 and    Fig. S3). Furthermore, despite the mean 
value of adhesion energies between the two cell lines 
being similar (1.8 ± 0.1 vs. 1.6 ± 0.04 nJ; Additional file 1: 
Table. S1), the median value was clearly higher for HEC-
1B compared to HEC-1A cells (0.859 vs. 0.056 nJ; Fig. 5). 
Therefore, the MUC1 expression levels altered the mag-
nitude of the L-selectin adhesive binding forces.
Secondly, the impact of GlcNAc expression in medi-
ating L-selectin binding was assessed, where increased 
GlcNAc expression in both HEC-1B and HEC-1A 
(Models B-2 & A-2) resulted in increased adhesion 
force (1076 ± 18 and 428 ± 6 pN) and adhesion energy 
(7.1 ± 0.2 and 2.0 ± 0.05 nJ) (Fig.  5; Additional file  1: 
Table S1). The greatest increase was seen in HEC-1B cells 
which had the highest level of GlcNAc expression for all 
models (Model B-2) (Additional file  1: Table  S1). Also, 
a reduction in GlcNAc expression in the HEC-1B and 
HEC-1A cell lines (Models B-3 & A-3) led to a decrease 
in adhesion force (352 ± 6 and 213 ± 4 pN) and adhesion 
energy (1.4 ± 0.02 and 0.8 ± 0.02 nJ) (Fig.  5). The great-
est decrease in these binding measurements was seen 
in HEC-1A cells (Model A-3) even though the reduced 
level of GlcNAc expression was comparable to HEC-1B 
cells (Model B-3; Additional file 1: Table S1). These data 
suggest that both the presence of MUC1 and levels of 
glycosylation mediate the strength of L-selectin binding. 
Interestingly, quantification of MUC16 expression on the 
HEC-1 cell surface revealed that the MUC1 poor HEC-
1A cells had increased expression of MUC16, whilst the 
MUC1 rich HEC-1B cells had reduced expression of 
MUC16 (Additional file  1: Fig S4). This data confirms 
the role of MUC1 in mediating the strength of L-selectin 
binding.
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Glycosylated MUC1 drives high affinity L‑selectin binding 
events
To assess the frequency of L-selectin binding events in 
relation to the MUC1 and glycosylation expression, force 
curve binding event mapping was performed (Fig. 6a). The 
VNTR structure of MUC1 is highly glycosylated and deco-
rated with sialyl-Lewis X and therefore acts as a scaffold 
for interactions with L-selectin [24, 29]. A greater number 
of L-selectin binding events were detected in MUC1 rich 
models (B-1 to B-3) compared to the MUC1 poor models 
(A-1 to A-3), which suggests that frequency of L-selectin 
binding increases when MUC1 is in abundance. Also, 
increased glycosylation in MUC1 rich models (B-2) fur-
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Fig. 2 Cell adhesion of HEC‑1A and HEC‑1B cells in the presence/absence of MUC1 specific siRNA. a A population wide screen (minimum 1000 
cells) assessed for the expression of MUC1 at the protein level using IN Cell microscope, in the presence and absence of MUC1 siRNA for both cell 
lines. b and c Topography AFM images of both cell lines in the presence and absence of MUC1 specific siRNA, scale bar 20 µm (b – control and 
MUC1 siRNA image Z range is 4.5 µm; c – Control image Z range is 8.8 µm, MUC1 siRNA image Z range is 4.0 µm). (d  and e) HEC‑1A and HEC‑1B cell 
mechanical and adhesive properties, stiffness (kPa), adhesion (pN) and deformation (nm), achieved with AFM QNM imaging were assessed in the 
presence and absence of MUC1 siRNA. All data shown is based on a minimum of three biological repeats with three cellular areas per repeat (n = 9), 
analysed as parametric data using 2 tailed T test. Significance given as * p < 0.05, **p < 0.001
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The tandemly repeating sequences within the VNTR 
structure of MUC1 could also potentially facilitate mul-
tiple interactions between the L-selectin functionalised 
probe and a single MUC1 molecule [24, 29]. Meas-
urement of the snap off forces produced during the 
AFM probe retraction can reveal the strength of indi-
vidual bonds made between the L-selectin and MUC1 
molecules (Additional file  1: Fig. S5a). The snap off 
forces measured for L-selectin binding to cell surfaces 
revealed that when expression of MUC1 and GlcNAc 
was high (Model B-2) the frequency of high affinity 
binding events increased to 400-600 pN (Fig. 6b, Addi-
tional file  1: Fig. S5b-g). When MUC1 expression was 
low but GlcNAc expression was high (Model A-2), the 
frequency of high affinity binding events was reduced 
to 200-400pN. The frequency of L-selectin binding 
events was further reduced when both MUC1 and Glc-
NAc expression was low, where 90 % of L-selectin bind-
ing events have snap off forces below 195pN. These 
data demonstrate that highly glycosylated MUC1 drives 
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Fig. 3 MUC1 VNTR specific antibody functionalised probe used to interrogate HEC‑1A and HEC‑1B cell surfaces. a Example SMFS force curves from 
HEC‑1A and HEC‑1B cell surfaces b the rupture force (pN) achieved from the surface of HEC‑1A and HEC‑1B cells achieved with a MUC1 antibody 
functionalized probe and an anti‑GAPDH antibody functionalized probe, in the presence and absence of MUC1 siRNA. c The percentage number 























































B-1 B-2 B-3 A-1 A-2 A-3 B-1 B-2 B-3 A-1 A-2 A-3 
Fig. 4 Mucin glycoprotein manipulation using inflammatory cytokine combinations.  a and b MUC1 and GLcNAc RNA expression data following 
treatment with TNFα and IFNγ cytokine treatment alone or in combination. (Models B‑1 & A‑1 – Control; B‑2–200IU IFNγ + 25 ng/ml TNFα; B‑3–25 
ng/ml TNFα; A‑2–200IU IFNγ; A‑3–25 ng/ml TNFα). All qPCR data shown as average and SD of a minimum 3 repeats. Significance given as * p < 0.05, 
**p < 0.001, ***p < 0.0001
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Discussion
The lack of clinically relevant model systems describing 
human fertility has resulted in a limited understanding 
of the functional roles of key cell surface molecules dur-
ing implantation. Mucins present on the surface of endo-
metrial epithelial, such as MUC1, have been implicated 
in fertility through a sialyl-Lewis X/L-selectin blastocyst 
adhesion system [13, 14]. However, the adhesive and anti-
adhesive properties of these mucins at the endometrial 
cell surface is difficult to resolve due to known discrepan-
cies between animal models and the human reproductive 
system, and also a lack of sensitivity in current in vitro 
models, meaning the role of MUC1 mucins in the repro-
ductive process had remained elusive [13–15, 17, 18]. 
To overcome these difficulties, we developed an in vitro 
approach using AFM analysis to not only decipher the 
intrinsic and extrinsic roles of MUC1 but also to examine 
the role of glycosylation in L-selectin binding.
AFM force measurements have been widely used to 
compare the mechanical properties of physiological and 
pathological cells within fertility and cancer research 
[30, 31]. Hsu et  al. 2016, measured the nanomechanical 
properties of RL95-2 cells (an endometrial carcinoma 
cell line) using PF-QNM where elasticity values ranged 
between 1 and 35 kPa and the adhesion between 200 and 
1900 pN, [32] which correlates well with nanomechanical 
measurements obtained from the HEC-1 cells used in 
this study. Other researchers have examined the elasticity 
of Ishikawa (endometrial adenocarcinoma), HeLa (cer-
vix adenocarcinoma) and MCF (breast adenocarcinoma) 
cells where the elasticity ranges from 0.7 to 2.73 kPa [33, 
34]. Such measurements were obtained with a colloidal 
AFM probe and in ‘force mapping’ mode, rather than PF-
QNM mode, which will have contributed to lower values 
of elasticity measured.
To examine if high intrinsic adhesion forces obtained at 
the cell surface were linked to MUC1 expression, the sur-
face of the endometrial HEC-1A and HEC-1B cell lines 
were examined with AFM, and MUC1 siRNA ablation 
assays revealed a correlation between reduced MUC1 
expression and a reduction in adhesion forces. Further-
more, anti-MUC1 antibody functionalised AFM probes 
used in SMFS anaysis revealed that increased MUC1 
expression led to an increase in the magnitude of rup-
ture forces at the cell surface, which reduced with siRNA 
MUC1 ablation. Sulchek et  al., 2005, demonstrated that 
the force required for MUC1-antibody bond separation is 
directly proportional to the number of bonds [35], where 
the rupture force for a single bond between a single-
chain variable fragment (scFv) fusion MUC1 antibody 
and a MUC1 peptide was approximately 150 pN. In this 
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Fig. 5 L‑selectin adhesion to endometrial cell surface models. L‑selectin binding to HEC‑1A and HEC‑1B cell models (B1‑3 and A1‑3) was 
characterized using a L‑selectin functionalised AFM probe with SMFS, resulting in measurements of adhesion (nN) and adhesion energy (nJ). SMFS 
data shown as box plots and frequency histograms produced from a minimum of 8000 curves, 5 cells per sample and minimum of 3 biological 
repeats (n = 15)
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MUC1 poor HEC-1A cells was between 100 and 200 pN, 
which is equivalent to a single MUC1-mAb interaction. 
In contrast MUC1 rich HEC-1B cell rupture forces gen-
erally occurred in the 200–300 pN range, suggesting that 
this rupture force resulted from multiple bond separa-
tions [36], possibly due to increased expression of MUC1 
on the cell surface. The presence of larger rupture forces 
occurring at relatively long distances away from the cell 
surface (see Additional file 1: Figure S4b-g) implies that 
the probe is breaking multiple bonds on the MUC1 mol-
ecule (specific adhesion molecules on the cell surface do 
not extend beyond > 50nm). These assays suggest that 
MUC1 contributes to intrinsic adhesive properties when 
present on the human endometrial cell surface.
Cytokines are involved in menstruation and implan-
tation processes within the endometrium [37], where 
cytokine expression reaches a maximum in the mid-
secretory phase of the menstruation cycle, concurrent 
with the window of implantation [38]. Interestingly, 
proinflammatory cytokines TNFα and IFNγ are present 
within the human endometrium throughout the men-
strual cycle. TNFα is expressed by the human endome-
trium in response to the presence of steroid hormones 























































































































































Fig. 6 L‑selectin binding events to endometrial cell surface models. a AFM SMFS force map images of individual L‑selectin binding events across 
the HEC‑1A and HEC‑1B endometrial cell surface models (B1‑3 and A1‑3), scale bar 1.5 µm. b Corresponding L‑selectin binding event data related 
to the snap‑off forces (pN) of the functionalized probe from the HEC‑1A and HEC‑1B cell models. All SMFS data shown in B is total number of events 
across a minimum of 6000 curves, across 5 cells, from 3 biological repeats (n = 15) [40]
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medium of preimplantation blastocysts, while TNFα 
receptors, TNFR-I and TNFR-II, are found expressed in 
the endometrial epithelium and in blastocysts. IFNγ is 
expressed in the luminal and glandular epithelia and IFNγ 
receptors, IFNγR-1 and IFNγR-2, are found expressed in 
the human endometrium [39]. Studies have found that 
expression of high levels of TNFα and IFNγ are impli-
cated in pregnancy loss in in vivo studies [39]. These 
proinflammatory cytokines greatly stimulate MUC1 
expression in various cellular models through STAT1α 
and nuclear factor B (NFкB) transcription factors binding 
to STAT and кB within in the MUC1 promoter [40–42]. 
Therefore, TNFα and IFNγ are biologically relevant treat-
ments to stimulate MUC1 expression.
In our study, we used the HEC-1A and HEC-1B cell 
lines treated with TNFα and IFNγ to model possible fer-
tile/infertile pathologies. The development of this in vitro 
model allowed us to not only compare MUC1 rich sys-
tems to MUC1 poor systems but also to compare vary-
ing levels of glycosylation, making the model extremely 
useful in deciphering the role of glycosylated MUC1 in 
fertility. Interestingly, when IFNγ was used alone or in 
combination with TNFα, there was an increase in mucin 
glycosylation in both cell lines, however, when TNFα 
was used alone there was a decrease in mucin glycosyla-
tion. The variation in mucin expression and glycosylation 
within our models could be linked to the dysregulated 
cytokine release in infertile patients, suggesting that 
cytokine interaction with their receptors may indirectly 
effect blastocyst apposition and adhesion to the endome-
trium surface [38].
Interestingly, studies have been performed using 
MECA-79, an antibody that recognises 6-sulfo sialyl-
Lewis X [43], and demonstrated that MECA-79 epitope 
selectin ligands increased from the proliferative to the 
secretory phase of the menstrual cycle in fertile indi-
viduals [29, 44], whilst the lack of MECA-79 expression 
in mid-luteal endometrial biopsies revealed a low or no 
chance of pregnancy [45]. Carson et  al., 2006 demon-
strated MECA-79 binds to MUC1 indicating the pres-
ence of sialyl-Lewis X on the glycosylated mucins [19] 
and Margarit et  al. 2009 correlated decreased expres-
sion of GlcNAc6ST-2  in fertile patients with decreased 
MECA-79 expression [20]. These studies reveal the 
importance of sialyl-Lewis X and glycosylation in human 
fertility, however an in vitro model to fully character-
ise the interaction between sialyl-Lewis X and its ligand 
L-selectin has been lacking. Our study has developed a 
reliable SMFS in vitro model capable of quantifying the 
extrinsic adhesive interactions between L-selectin and 
sialyl-Lewis X carrying mucins which are implicated in 
blastocyst binding to the endometrial cell surface.
The initial interaction of the blastocyst with the cell 
surface occurs with the transmembrane mucins which 
extend well beyond the cell surface (200-500 nm) where 
only MUC1 and MUC16 molecules are present due to 
their extended structures [46, 47]. To elucidate the extrin-
sic adhesion interactions occurring between L-selectin 
and glycosylated mucins, SMFS was used characterise 
this selectin-ligand interaction [26, 48], and revealed that 
L-selectin binds more strongly to the ligands present 
on MUC1 rich cell surfaces when compared to MUC1 
poor cell surfaces. Furthermore, L-selectin appeared to 
bind more strongly to highly glycosylated MUC1, indi-
cating that blastocyst adhesion to highly glycosylated 
MUC1 mucins would be enhanced. Cellular AFM force 
mapping combined with examination of the snap-off 
forces provided further confirmation of the importance 
of highly glycosylated MUC1 in fertility, as L-selectin 
binding events were greater in frequency and magnitude 
(400–600 pN) on highly glycosylated MUC1 rich cell 
lines compared to highly glycosylated MUC1 poor cell 
lines (200–400 pN). As the force required for bond sep-
aration is directly proportional to the number of bonds 
[24], the increase in the magnitude of L-selectin binding 
for highly glycosylated MUC1 is potentially due to mul-
tiple bonds being formed between the L-selectin func-
tionalised probe and the VNTR on the mucin strands. 
Importantly, this data demonstrates the significance of 
highly glycosylated MUC1 in the adhesion mechanism 
to L-selectin. Other cell surface adhesion related mol-
ecules do not extend beyond 50 nm from the cell sur-
face [46, 47]. Therefore, the long-range interactions that 
occur between the mucin molecules and the AFM probe 
can be successful captured by AFM Force Retraction 
experiments.
Conclusions
The ability of the blastocyst to implant into the endo-
metrial surface is a delicate balance between the adhe-
sive and anti-adhesive properties of the mucin protein 
dominated endometrial surface layer [15–17]. Previ-
ous in vivo studies have demonstrated that the mucin 
layer acts as a natural barrier to the embryo attachment 
however, human expression of MUC1 is high during 
per-implantation [17, 18]. This study demonstrated that 
MUC1 contributes to both the intrinsic and extrinsic cel-
lular adhesive properties which may function to facili-
tate trophoblast binding to the endometrial cell surface 
through the L-selectin/sialyl-Lewis x adhesion system 
before subsequent implantation. MUC1 extrinsic adhe-
sive properties are linked to mucin glycosylation status, 
where greater glycosylation results in increased L-selec-
tin binding. The heterogeneity of MUC1 expression in 
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the endometrium may define a receptive site for implan-
tation, facilitating the initial adhesion of blastocyst to the 
endometrial surface layer before implantation [17]. Fur-
thermore, the application of SMFS is a unique approach 
in the endometrium which has been able to quantify the 
strength and frequency of L-selectin binding and deter-




Endometrial adenocarcinoma HEC-1A and HEC-1B cell 
lines (ATCC® HTB-112 and ATCC® HTB-113 respec-
tively; www.lgcst andar ds-atcc.org) [52] were maintained 
 (37oC, 5 %  CO2) in DMEM/F-12 + Glutamax™ full media 
(Gibco, Thermo Fisher, UK) supplemented with 10 % 
(v/v) foetal bovine serum (FBS), sodium bicarbonate 
1mM, sodium pyruvate 1mM and 1 % (v/v) antibiotic-
antimycotic solution in plastic culture vessels (25  cm2, 75 
 cm2, 125  cm2). Cells were supplemented with full serum 
media every two days and passaged when confluent. Only 
cells passaged more than two times were used in this 
study.
Atomic force microscopy PFQNM imaging
Cell lines were cultured in 50 mm diameter glass-bot-
tomed dishes (WillCo Wells, Amsterdam, The Nether-
lands) for use on the Bioscope Catalyst II AFM (Bruker, 
Coventry, UK). After the desired treatment regime, the 
culture media was replaced with 2 ml of pre-warmed 
DMEM/F-12 phenol red free media (Gibco, Thermo 
Fisher, UK) prior to live cell imaging. Cells were imaged 
over a maximum time of 90 mins at 37 °C. ScanAsyst 
Fluid cantilevers (Bruker, Coventry, UK) were used with a 
nominal spring constant of 0.7 N/m and a tip apex radius 
of 20–60 nm. The indentation force was kept below < 1 
nN, scan rate was 0.5 Hz, resolution was 128 samples/line 
and scan area encompassed 50–150 µm of the cell mon-
olayer. Processing of PFQNM images was undertaken 
with the Bruker Nanoscope software, following standard 
protocol [53, 54]. Data shown is based on a minimum 
of three biological repeats, analysed as parametric data 
using 2 tailed T test. Significance given as * p < 0.05, ** 
p < 0.001 and *** p < 0.0001.
MUC1 siRNA preparation
HEC-1A and HEC-1B cells were removed from the cul-
ture vessels with 0.25 % (w/v) trypsin-EDTA (Gibco, 
Thermo Fisher, UK) and re-suspended in cell culture 
media. 1 ml of cell suspension (approximately 8 × 104 
cells) was aspirated onto round glass-bottomed 30 mm 
dishes (WillCo Wells, Amsterdam, The Netherlands), 
and cells allowed to attach for 5 mins. 2 ml of cell culture 
media was then added and cells incubated for 24  h (37 
°C, 5 %  CO2). The cell culture medium was then replaced 
with 2.5 ml antibiotic free culture media supplemented 
with 500 µl OPTI-C medium, 10 µl MUC1 siRNA (Santa 
Cruz Biotechnology, Heidelberg, Germany) and 7.5 µl 
lipofectamine RNAiMAX (Invitrogen) before the cells 
were further incubated for 48  h (37 °C, 5 %  CO2). This 
transfection preparation was incubated for 20 mins at 25 
°C prior to application.
Population based MUC1 protein screening
Total protein was assessed with IN Cell analyser 2000 
(GE Healthcare, Amersham, UK). Cells were fixed with 
4 % (w/v) paraformaldehyde then stained with mouse 
MUC1 ND antibody (Santa Cruz Biotechnology, Heidel-
berg, Germany) prior to incubation with an anti-mouse 
Texas Red conjugated secondary antibody (emission 620 
nm; Molecular Probes, Thermo Fisher UK). Cell nuclei 
were counter stained with 4’,6-diamidino-2-phenylindole, 
DAPI (emission 470 nm; Invitrogen, Thermo Fisher, UK), 
where PBS wash steps followed each staining process. 
Five low magnification images of approximately 1000 
cells in total were achieved. An object segmentation 
protocol within the IN Cell Developer software masked 
the nuclei by segmenting on intensity in the DAPI chan-
nel. Information about the fluorescence output in the 
Texas Red channel (MUC1) within this ‘cell region’ was 
recorded and each cell assigned an output value. All data 
shown is based on a minimum of three biological repeats, 
analysed as parametric data using 2 tailed T test. Signifi-
cance given as * p < 0.05, **p < 0.001.
Functionalization (anti‑MUC1 antibody, anti‑GAPDH 
antibody and L‑selectin) of AFM probes
Direct functionalization of AFM probes (DNP-10 D tips, 
Bruker, Coventry, UK) was performed by rinsing the 
probes in deionised  H2O x5, before immersion in HAP-
TES buffer (0.1 % v/v, pH 7.0; Sigma Aldrich, Gillingham, 
UK) for 7 mins at 25 °C. The sialianized probes were 
rinsed x5 in deionised  H2O before immersion in glutaral-
dehyde (0.5 % w/v pH 7.0) for 7 mins at 25 °C. The probes 
were further rinsed in deionised  H2O before being 
immersed in either 200 µg/ml mouse VU4H5 anti-MUC1 
antibody or 200 µg/ml mouse anti-GAPDH antibody 
(Santa Cruz Biotechnology, Heidelberg, Germany) for 15 
mins at 25 °C. The AFM probes were then rinsed x5 in 
Tris HCl (5 % w/v pH 7.0) before immersion and storage 
in Tris HCl. Linker functionalisation of AFM probes with 
L-selectin and associated negative control followed a two-
step chemical procedure [28]. The AFM probes (DNP-
10; Bruker-nano, Coventry, UK) were briefly washed in 
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acetone for 5 mins before immersion in piranha solution 
 (H2SO4:H2O2; 3:1; v/v) for 30 mins. The cantilevers were 
then incubated in 1 mL of APTES (0.1 % w/v, pH 7.2) for 
10 mins to create an amino-terminated tip surface. The 
probes were then rinsed with PBS (x5) followed by rins-
ing with water (x5) before incubation in LC-SPDP (suc-
cinimidyl 6-(3(2-pyrifyldithio)propionamido)hexanoate) 
for 45 mins to obtain a reactive pyridyl-disulfide surface. 
The LC-SPDP functionalised probes were then rinsed 
again in PBS (x5) and water (x5). L-selectin (200 µg/mL; 
Randox Laboratories, County Antrim, UK) was modified 
by reaction with SATP (N-succinimidyl-S-acetylthiopro-
pionate) for 30 mins in order to produce a free sulfhy-
dryl group, before a series of purification steps through 
a dextran salting column (5.0k MWCO;  Pierce™, Thermo 
Fisher, UK) were performed. LC-SPDP functionalized 
probes were then incubated in the presence of thiolated-
activated L-selectin, forming an L-selectin functionalised 
probe through a disulfide exchange reaction with SPDP-
activated protein [55]. The AFM probes were functional-
ised fresh before every experiment and kept submerged 
in a solution of 20 mM sodium phosphate, 0.15 M NaCl 
and 10 mM EDTA at pH 7.2. ATPES was freshly made 
and adjusted to pH 7 before the functionalisation to pre-
vent hydrolyses of ATPES which could interfere with sial-
inization reaction with the AFM tip.
Force mapping with the functionalised probe
Cell lines were cultured in 35 mm diameter glass-bot-
tomed dishes (Fluorodish, WPI Precision Instruments, 
Hertforshire, UK) for use on the Nanowizard II AFM 
(JPK BioAFM, Berlin, Germany). HEC-1A and HEC-1B 
cell monolayers were probed for single molecule force 
adhesive interactions by using L-selectin functionalised, 
anti-GAPDH functionalised and anti-MUC1 antibody 
functionalised AFM probes at 37  °C (DNP-10 D tips, 
Bruker Nano, Coventry, UK). AFM probes functional-
ised with anti-GAPDH were used as a negative control 
as the cell surface is devoid of any GAPDH. Probes with 
nominal spring constants of 0.065  N/m following func-
tionalization were used (confirmed with the Thermal 
tune method). The maximum load force was 1.5 nN, z 
speed was 3 µm/s (extend and retract) and a force delay 
of 200 ms applied. Force volume maps with 16–32 pixels/
side were acquired on a minimum of 3 cellular locations, 
where each experiment was performed at least three 
times with different yet identically prepared AFM probes 
and surfaces. This resulted in a minimum of 768 force 
curves per sample type. Moderate variations in the noise 
of force curves across measurements are due to varia-
tions in the AFM probes.
All pixels/points for each force curve (1024) was col-
lected and included in the retraction curve data to ensure 
all binding events were considered. All force curve qual-
ity control features of the JPK software were used. Only 
curves where the retraction curve returned to the base-
line were included for analysis and a goodness of fit of 
R = 0.85 or more were used. Vertical deflection (baseline) 
and contact point were adjusted to 0 nm. Identical pro-
cessing conditions were applied to all force volume files 
using a saved batch processing algorithm.
Force curves were analyzed with JPK data processing 
software to fit steps to the retraction curves in order to 
detect specific surface interactions. Steps were fitted to 
the curve using in built features of the software provid-
ing data on the size of the step (pN) and the distance it 
occurred from the contact point. Only rupture events 
appearing at tip-sample distances larger than 200 nm 
were considered for further analysis to avoid bias by non-
specific tip-sample interactions. The two parameters to 
control the algorithm are “smoothing’’ which defines how 
smooth the ‘slowly varying background signal’ is and ‘sig-
nificance’ which sets the threshold below which steps are 
considered to be noise (and are thus discarded). A sig-
nificance value of 0.001 means that the only step heights 
accepted have a probability of less than 1/1000 of being 
due to noise fluctuations (based on an estimate for the 
RMS of F_noise) .
The SMFS force maps with L-selectin functionalised 
probes illustrate the spatial location of each binding 
occurrence on the cell surface and the colour of the pixel 
indicates the number of binding steps experienced on the 
retraction curve. For the MUC1-antibody functionalised 
probes, the frequency of surface binding was displayed 
as the percentage of positive and negative binding force 
curves where a student’s 2 tailed T-test was performed to 
assess significance. Significance given as *p < 0.05.
Cytokine treatment
Prior to cytokine treatment, cell culture media containing 
stripped FBS serum was added to the HEC-1A and HEC-
1B cell cultures for 24  h to ensure the removal of large 
molecular weight proteins and steroids. The cells were 
then treated with two cytokines TNFα and IFNγ (Milte-
nyi Biotec, Woking, UK) either alone or in combination 
for 48 h (37 °C, 5 %  CO2). HEC-1B and HEC-1A cell mod-
els (B-1 and A-1) were the control samples. In the HEC-
1B cell line, model B-2 consisted of the treatment 200 IU 
IFNγ + 25 ng/ml TNFα while model B-3 consisted of 
the treatment 25 ng/ml TNFα. In the HEC-1A cell line, 
model A-2 consisted of the treatment 200IU IFNγ, while 
model A-3 used the treatment 25 ng/ml TNFα.
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Real time quantitative polymerase chain reaction 
(RT‑QPCR)
Total RNA was isolated from the cell models using the 
RNeasy mini and DNAseI kit (74,106 and 79,254; Qiagen, 
Manchester, UK) following the manufacturer’s instruc-
tions. The concentration of extracted total RNA was 
measured using a Nano-drop ND-1000 spectrophotom-
eter (Thermo Fisher, UK) and samples adjusted to 100 
µg/ml RNA using RNAse free  H20 (Qiagen, Manchester, 
UK). cDNA was obtained using the high capacity cDNA 
kit (4,387,406, Applied Biosystems, Thermo Fisher, UK) 
and amplified using gene specific primer pairs to obtain 
a PCR product between 75 and 263  bp for each of the 
genes under study (MUC1, GlcNac, see Additional file 2). 
Real time QPCR amplifications were conducted in tripli-
cate in 96-well optical reaction plates (BioRad, Watford, 
UK) and run on the CfX-96 PCR detection system (Bio-
rad, Watford, UK). RP-L19 was used as a housekeeping 
gene, and genomic DNA and RNA were used as positive 
and negative controls respectively. All expression levels 
were normalized with values obtained for the internal 
reference gene RP-L19. Data shown was analysed as using 
one-way ANOVA test. Significance given as *p < 0.05.
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